Tech Company Financing Transactions

Pervasis Therapeutics Funding Round

Pervasis Therapeutics, based in Cambridge, secured $12 million in funding from Highland Capital Partners, Flagship Pioneering and Polaris Partners.

Transaction Overview

Company Name
Pervasis Therapeutics
Announced On
9/30/2005
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series B
Investors

Highland Capital Partners (Lead Investor) (Robert Higgins)

Flagship Pioneering (Ed Kania)

Polaris Partners (Terry McGuire)

Proceeds Purpose
The financing will be used to continue clinical development of the company's first product, a combination device for patients with vascular disease.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
One Kendall Square B6101
Cambridge, MA 02139
USA
Phone
(617) 621-3407
Website
www.pervasistx.com
Email Address
[email protected]
Overview
Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.
Profile
Pervasis Therapeutics LinkedIn Company Profile
Social Media
Pervasis Therapeutics Company Twitter Account
Company News
Pervasis Therapeutics News
Facebook
Pervasis Therapeutics on Facebook
YouTube
Pervasis Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frederic Chereau
  Frederic Chereau LinkedIn Profile  Frederic Chereau Twitter Account  Frederic Chereau News  Frederic Chereau on Facebook
Co-Founder
Helen Nugent
  Helen Nugent LinkedIn Profile  Helen Nugent Twitter Account  Helen Nugent News  Helen Nugent on Facebook
VP - Bus. Development
Margaret O'Toole
  Margaret O'Toole LinkedIn Profile  Margaret O'Toole Twitter Account  Margaret O'Toole News  Margaret O'Toole on Facebook
VP - Manufacturing
Jack Harvey
  Jack Harvey LinkedIn Profile  Jack Harvey Twitter Account  Jack Harvey News  Jack Harvey on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/30/2005: Agoura Technologies venture capital transaction
Next: 9/30/2005: Apneon venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.